Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02637713 · ClinicalTrials.gov registry record · NA

Management of Reflux After Sleeve Using Stretta

A NA study, sponsored by Montefiore Medical Center.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT02637713 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02637713, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Gastroesophageal reflux disease (GERD) is a frequently seen entity after sleeve gastrectomy. Management of GERD after sleeve is difficult given limited treatment modalities. Stretta is an endoscopic FDA approved device that improves symptoms of GERD, there is minimal information about its use on patients after sleeve. This registry will attempt to get information regarding the treatment of reflux using Stretta after sleeve gastrectomy.

Interventions

  • DEVICE Stretta
  • PROCEDURE Radiofrequency (RF) Energy to the LES (Stretta Procedure)

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2016-03
Est. Completion 2019-05
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT02637713

The ClinicalTrials.gov registry entry for NCT02637713 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Stretta is the first listed.

NCT02637713 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02637713 about?

NCT02637713 is a clinical study titled "Management of Reflux After Sleeve Using Stretta". Gastroesophageal reflux disease (GERD) is a frequently seen entity after sleeve gastrectomy. Management of GERD after sleeve is difficult given limited treatment modalities. Stretta is an endoscopic FDA approved device that improves symptoms of GERD, there is minimal information about its use on pat...

What is the current status of trial NCT02637713?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2016-03. Estimated completion is 2019-05.

What interventions are being tested in trial NCT02637713?

The interventions under investigation include: Stretta (DEVICE), Radiofrequency (RF) Energy to the LES (Stretta Procedure) (PROCEDURE).

Who is sponsoring clinical trial NCT02637713?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.